Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network

Weber, Damien; Wang, Yucai; Miller, Robert; Villa, Salvador; Zaucha, Renata; Pica, Alessia; Poortmans, Philip; ANACAK, YAVUZ; Ozygit, Gokhan; Baumert, Birgitta; Haller, Guy; Preusser, Matthias; Li, Jing

doi:10.1093/neuonc/nou293

Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network

Atıf İçin Kopyala

Weber D. C. , Wang Y., Miller R., Villa S., Zaucha R., Pica A., ...Daha Fazla

NEURO-ONCOLOGY, cilt.17, sa.4, ss.588-595, 2015 (SCI İndekslerine Giren Dergi)

Cilt numarası: 17 Konu: 4
Basım Tarihi: 2015
Doi Numarası: 10.1093/neuonc/nou293
Dergi Adı: NEURO-ONCOLOGY
Sayfa Sayıları: ss.588-595

Özet

Background. Spinal myxopapillary ependymomas (MPEs) are slowly growing ependymal gliomas with preferential manifestation in young adults. The aim of this study was to assess the outcome of patients with MPE treated with surgery, radiotherapy (RT), and/or chemotherapy.